Zdrowie i gospodarka · 16/11/1994

FDA Issues Final Order on Allergenic Extracts Classified in Category IIIB

The Food and Drug Administration (FDA) is issuing a final order regarding most allergenic extracts classified in Category IIIB, revoking licenses for products without a hearing request, and authorizing the manufacture of specific products under U.S. licenses. The agency is still considering a pending hearing request for Category IIIB injectable Poison Ivy Extract.